PF-05381941
PF-05381941 is a potent dual inhibitor of TAK1/p38α, with IC50s of 156 and186 nM, respectively[1].
Product Specifications
CAS Number
[1474022-02-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
MAP3K; p38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pf-05381941.html
Purity
99.73
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(OC2=CC=NC=C2)C(C)=C1)NC3=CC(C(C)(C)C)=NN3C4=CC=CC(C#N)=C4
Molecular Formula
C27H26N6O2
Molecular Weight
466.53
Precautions
H302, H315, H319
References & Citations
[1]Kilty I, et al. TAK1 inhibition in the DFG-out conformation. Chem Biol Drug Des. 2013;82 (5) :500-505.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P38α
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC216091L2 10 µg
SEMCAP3 (PDZRN3) (NM_015009) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 